Eve Dryer is a highly renowned voice on behalf of the Rare Disease patient community and has served as a patient advocacy leader for more than 25 years. She is also known for her work in health equity and diversity, and in 2020 helped to found the Rare Disease Diversity Coalition. She recently retired from Travere Therapeutics, where she served as Vice President for Patient Advocacy.
She previously helped to launch the Teens for Pink website, engaging African American teenagers in breast cancer education and helping as family healthcare navigators. She spent 12 years as founder and partner in a Philadelphia-based healthcare PR agency, with clients including AstraZeneca, GlaxoSmithKline, Janssen and Eisai.
She is on the Board of Sisters Network Inc. as well as serving on the Boards of the national ALS Association and NephCure. She was the Healthcare Businesswomen’s Association 2013 global STAR honoree, and was recognized in the PharmaVOICE 100 in 2008, 2016 and 2021.
